Is Low Sodium a Sign of Cancer? What to Know

Low sodium can be a sign of cancer, but it usually isn’t. Hyponatremia (sodium below 135 mmol/L) is the most common electrolyte disorder in the general hospital population, and the vast majority of cases are caused by medications, heart failure, liver disease, kidney problems, or simple dehydration. That said, the link to certain cancers is real and well-documented. An estimated 20% to 50% of cancer patients develop low sodium at some point during their illness, making it the most frequent electrolyte abnormality in oncology.

Which Cancers Are Most Linked to Low Sodium

The cancers most commonly responsible for dropping sodium levels are lung cancer, breast cancer, and head and neck cancers. Small cell lung cancer stands out as the strongest association by far. Up to 44% of small cell lung cancer patients develop clinically significant low sodium, often because the tumor itself produces a hormone that disrupts the body’s water balance.

The mechanism works like this: certain tumors produce a hormone called ADH (antidiuretic hormone) that normally tells your kidneys to hold onto water. When a tumor pumps out this hormone on its own, your body retains excess water, which dilutes the sodium in your blood. This is called SIADH, or syndrome of inappropriate antidiuretic hormone secretion. Lab studies have confirmed that virtually all small cell lung cancer cell lines produce this hormone, while most other lung cancer types do not.

Beyond lung and breast cancers, SIADH has been reported in patients with cancers of the digestive tract, olfactory neuroblastomas, and various rare tumors. About 3% of patients with head and neck cancers develop it. But these are less common scenarios, and case reports remain limited.

How Low Sodium Affects Cancer Prognosis

When low sodium does appear alongside cancer, it tends to signal a more aggressive disease. A Danish study tracking 453 small cell lung cancer patients over 10 years found that those with low sodium survived roughly 50% less time than those with normal levels. Similar patterns have been observed in kidney cancer, stomach cancer, and non-Hodgkin’s lymphoma.

A larger study of 3,886 patients found that patients with blood cancers tended to have only mildly low sodium, while patients with solid tumors were more likely to have moderate or severe drops. Across all cancer types, patients whose sodium levels returned to normal during treatment had better outcomes than those whose levels stayed low. In other words, sodium level can serve as a rough indicator of how well treatment is working.

Many Common Conditions Cause Low Sodium

Before jumping to worst-case scenarios, it helps to know just how many everyday causes of low sodium exist. The list is long, and most entries have nothing to do with cancer:

  • Medications: Thiazide diuretics (water pills), antidepressants including SSRIs, anti-seizure drugs, opioids, and even NSAIDs like ibuprofen can lower sodium.
  • Heart, liver, and kidney disease: Congestive heart failure, cirrhosis, and chronic kidney failure are among the most common causes of persistently low sodium.
  • Hormonal conditions: An underactive thyroid or adrenal insufficiency (Addison’s disease) both interfere with sodium regulation.
  • Gastrointestinal losses: Prolonged vomiting or diarrhea can deplete sodium quickly.
  • Excessive water intake: Drinking large amounts of water without adequate food intake, sometimes called “water intoxication,” dilutes sodium. This can happen during endurance exercise, with certain psychiatric conditions, or even from heavy beer consumption with little food (sometimes called beer potomania).
  • Diet: A very low-solute diet, sometimes described as a “tea-and-toast diet” common in older adults, can contribute to low sodium over time.

If you’re taking any of the medications listed above, that’s a far more likely explanation than an underlying malignancy. Thiazide diuretics alone account for a huge share of low sodium cases in older adults.

What Low Sodium Feels Like

Mild drops in sodium (130 to 135 mmol/L) often produce no noticeable symptoms at all. You might feel slightly fatigued or “off” without being able to pinpoint why. As levels fall further into the moderate range (125 to 129 mmol/L), nausea, headaches, confusion, and muscle cramps become more common. Profound hyponatremia, below 125 mmol/L, can cause seizures, loss of consciousness, and in rare cases can be life-threatening.

These symptoms are the same regardless of the underlying cause. Nothing about the way low sodium feels can distinguish a cancer-related case from one caused by a medication or heart condition. That distinction requires further testing.

How Doctors Investigate the Cause

When a blood test reveals low sodium, the diagnostic process focuses on narrowing down why. Your doctor will typically assess your fluid status (whether you seem dehydrated, normally hydrated, or retaining fluid), check additional blood and urine tests to understand how your kidneys are handling water and salt, and review your medication list carefully.

If the pattern points to SIADH and no obvious medication or hormonal cause explains it, imaging of the chest is a common next step, given the strong association between SIADH and lung tumors. This is especially true if you have risk factors like a history of smoking. But reaching the point where cancer is seriously suspected usually requires ruling out the more common explanations first.

Low Sodium During Cancer Treatment

For people already diagnosed with cancer, low sodium can also develop as a side effect of treatment rather than from the cancer itself. Several chemotherapy drugs are known to cause it. Some do so by triggering inappropriate hormone release through toxic effects on the brain’s hormonal control center. Others interfere directly with the kidneys’ ability to reabsorb sodium. Platinum-based chemotherapy, for instance, can damage kidney tubules and cause sodium to be lost in urine.

This distinction matters because treatment-related low sodium is typically manageable and reversible once the offending drug is adjusted, while tumor-driven low sodium may persist until the cancer itself responds to therapy. Either way, oncology teams routinely monitor sodium levels throughout treatment and adjust fluid intake or medications accordingly.

Putting the Risk in Perspective

If you found a low sodium result on routine bloodwork and you’re wondering whether it could mean cancer, the honest answer is that it’s possible but statistically unlikely. Low sodium is one of the most common lab abnormalities in medicine, period. It shows up in hospitalized patients, in people taking everyday medications, and in otherwise healthy people who happen to drink too much water or eat too little salt. The vast majority of cases resolve once the underlying cause, which is usually mundane, is addressed.

Where low sodium becomes a more meaningful red flag is when it’s persistent, unexplained by medications or known conditions, and accompanied by other concerning signs like unexplained weight loss, a chronic cough, or a new mass. In that context, it can be an important early clue, particularly for lung cancer. Patients whose low sodium normalizes after treatment consistently do better than those whose levels remain depressed, suggesting that tracking sodium over time provides useful information about disease trajectory.